Project to focus on drug development for schizophrenia, depression

01/19/2010 | EurekAlert!

An international team of researchers, headed by H. Lundbeck A/S and King's College London, has formed the Novel Methods leading to New Medications in Depression and Schizophrenia, an academic-industry research tie-up that will focus on finding new ways to develop treatments for schizophrenia and depression. The project aims to develop new animal models for brain studies, as well as hardware and analysis methods that can be used in brain imaging, including MRI and PET.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC